Could This Seattle Pot Stock SOAR as Legal Weed Market Expands?
Fifteen states plus the District of Columbia now permit the recreational use of cannabis and Congress is on track to decriminalize marijuana possession on the federal level. As a result, the North American cannabis market is expected to TRIPLE in size from $30 billion to $100 billion by the year 2027 – and one Seattle manufacturer is poised to cash in!
Details in Brand-New Special Report!
Angela L. Wirick, insider at AtriCure
Angela L. Wirick Insider Alerts

Get notified the next time Angela L. Wirick buys or sells AtriCure stock. Enter your email address below to get our daily insider buying and selling report.

Angela L. Wirick Insider Information

CFO of AtriCure
Angela L. Wirick, C.P.A. was appointed Chief Financial Officer in August 2020. Immediately prior to this, Ms. Wirick served as our Vice President, Finance for four years, where she led the global accounting and finance functions of the Company and supported strategic initiatives. Ms. Wirick joined the Company in 2014 as Director, Finance. Prior to AtriCure, Ms. Wirick began her career in public accounting at Arthur Andersen LLP and Deloitte & Touche LLP, serving clients in a variety of industries over fourteen years. Ms. Wirick received her B.S.B.A. in Accounting from the University of Dayton and is a Certified Public Accountant.

What is Angela L. Wirick's net worth?

The estimated net worth of Angela L. Wirick is at least $5.14 million as of August 6th, 2021. Ms. Wirick owns 77,941 shares of AtriCure stock worth more than $5,144,106 as of November 30th. This net worth evaluation does not reflect any other assets that Ms. Wirick may own. Learn More.

What is Angela L. Wirick's salary?

As the CFO of AtriCure, Inc., Ms. Wirick earned a total compensation package of $2,291,595.00 in 2020. Ms. Wirick earned a salary of $327,920.00, stock awards of $1,889,356.00, non-equity compensation of $65,769.00, and other compensation of $8,550.00.

How do I contact Angela L. Wirick?

The corporate mailing address for Ms. Wirick and other AtriCure executives is 7555 INNOVATION WAY, MASON OH, 45040. AtriCure can also be reached via phone at (513) 755-4100.

Has Angela L. Wirick been buying or selling shares of AtriCure?

Angela L. Wirick has not been actively trading shares of AtriCure during the last quarter. Most recently, Angela L. Wirick sold 5,939 shares of the business's stock in a transaction on Friday, August 6th. The shares were sold at an average price of $80.21, for a transaction totalling $476,367.19. Following the completion of the sale, the chief financial officer now directly owns 77,941 shares of the company's stock, valued at $6,251,647.61.

Who are AtriCure's active insiders?

AtriCure's insider roster includes Tonya Austin (Insider), Mark Collar (Director), Vinayak Doraiswamy (Insider), Scott Drake (Director), Regina Groves (Director), David Grumhaus, Jr. (Portfolio Manager), Justin Noznesky (Insider), Salvatore Privitera (Insider), Douglas Seith (COO), Sven Wehrwein (Director), and Angela Wirick (CFO).

Are insiders buying or selling shares of AtriCure?

During the last year, AtriCure insiders bought shares 1 times. They purchased a total of 34 shares worth more than $2,607.12. During the last year, insiders at the medical device company sold shares 37 times. They sold a total of 518,265 shares worth more than $33,182,513.99. The most recent insider tranaction occured on November, 12th when insider Tonya Austin sold 2,732 shares worth more than $214,598.60. Insiders at AtriCure own 3.6 % of the company.

Information on this page was last updated on 11/12/2021.

Angela L. Wirick Insider Trading History at AtriCure

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/6/2021Sell5,939$80.21$476,367.1977,941View SEC Filing Icon  
See Full Table

Angela L. Wirick Buying and Selling Activity at AtriCure

This chart shows Angela L. Wirick's buying and selling at AtriCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AtriCure Company Overview

AtriCure logo
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in Mason, OH.
Read More

Today's Range

Now: $66.00
Low: $65.94
High: $73.51

50 Day Range

MA: $74.38
Low: $66.00
High: $87.14

2 Week Range

Now: $66.00
Low: $42.50
High: $89.18

Volume

347,320 shs

Average Volume

236,097 shs

Market Capitalization

$3.03 billion

P/E Ratio

69.47

Dividend Yield

N/A

Beta

1.1
2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas